{"disease":{"id":"rectal-cancer-adenocarcinoma","name":"rectal cancer adenocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04739722","title":"Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":14263,"lead_sponsor_name":"Geneoscopy, Inc.","has_results":true},{"nct_id":"NCT06059963","title":"A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Universal Diagnostics","has_results":false},{"nct_id":"NCT03517332","title":"Circulating Tumor DNA Exposure in Peripheral Blood","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Quantgene Inc.","has_results":false},{"nct_id":"NCT06978595","title":"Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies","phase":"","overall_status":"COMPLETED","enrollment_count":8171,"lead_sponsor_name":"asmaa salama ibrahim","has_results":false},{"nct_id":"NCT06864338","title":"Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test","phase":"","overall_status":"RECRUITING","enrollment_count":2700,"lead_sponsor_name":"Mainz Biomed","has_results":false},{"nct_id":"NCT06342440","title":"Early Detection of Advanced Adenomas and Colorectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT03699163","title":"The Colorectal Breath Analysis (COBRA) Study","phase":"","overall_status":"COMPLETED","enrollment_count":1855,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT06076811","title":"DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies","phase":"","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04722055","title":"A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China","phase":"","overall_status":"COMPLETED","enrollment_count":1273,"lead_sponsor_name":"Creative Biosciences (Guangzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT03367611","title":"Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":1258,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06050447","title":"Factors Affecting the Results of Treatment of Patients With Colorectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Immanuel Kant Baltic Federal University","has_results":false},{"nct_id":"NCT06445062","title":"Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":1130,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT07319104","title":"Liquid Biopsy in Early Colorectal Lesions","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04895709","title":"A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":949,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07223424","title":"Patient Preference for Subcutaneous vs. Intravenous Immune Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":880,"lead_sponsor_name":"Diwakar Davar","has_results":false},{"nct_id":"NCT05374369","title":"Retrospective Analysis of Colorectal Cancer Screening Results","phase":"","overall_status":"COMPLETED","enrollment_count":822,"lead_sponsor_name":"Creative Biosciences (Guangzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT06073431","title":"LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT05379985","title":"Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":754,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT05038254","title":"Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":750,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04140526","title":"Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":733,"lead_sponsor_name":"OncoC4, Inc.","has_results":false},{"nct_id":"NCT05078047","title":"Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":646,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT06040541","title":"Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":604,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT05517811","title":"Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT06314958","title":"Stage II/III Colorectal Cancer Recurrence","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT06339346","title":"Analysis of Histopathological Factors Predictive of Lymph Node Involvement and Management Practices in pT1 Colorectal Cancers Treated by Primary Endoscopic Resection","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06342401","title":"Early Onset Colorectal Cancer Detection","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT02758951","title":"Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":358,"lead_sponsor_name":"Koen Rovers","has_results":false},{"nct_id":"NCT07410767","title":"Advanced Endoscopic Resections for Rectal Neoplasms","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Jagiellonian University","has_results":false},{"nct_id":"NCT02890069","title":"A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":298,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT02900664","title":"A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":283,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05620134","title":"Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":263,"lead_sponsor_name":"Salubris Biotherapeutics Inc","has_results":false},{"nct_id":"NCT07318805","title":"A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT07223047","title":"A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":252,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07107815","title":"A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":250,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06682793","title":"A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"A2 Biotherapeutics Inc.","has_results":false},{"nct_id":"NCT06792435","title":"XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Evopoint Biosciences Inc.","has_results":false},{"nct_id":"NCT07361575","title":"Study Comparing the Quality of Colon Cleanliness With Prepackaged LRD (Low-residue Diet) vs. Guided (POG).","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":230,"lead_sponsor_name":"Clinique Paris-Bercy","has_results":false},{"nct_id":"NCT05462717","title":"Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":222,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT06428409","title":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06328361","title":"Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT03765736","title":"Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial","phase":"","overall_status":"TERMINATED","enrollment_count":199,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT03752398","title":"A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":198,"lead_sponsor_name":"Xencor, Inc.","has_results":false},{"nct_id":"NCT07500259","title":"Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":188,"lead_sponsor_name":"Luxembourg Institute of Health","has_results":false},{"nct_id":"NCT03899870","title":"Factors Predicting Recurrence in Rectal Cancer After Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"ammar houssem","has_results":false},{"nct_id":"NCT05480306","title":"Phase 2 Study of DKN-01 in Colorectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"Leap Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04802876","title":"Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":184,"lead_sponsor_name":"SOLTI Breast Cancer Research Group","has_results":false},{"nct_id":"NCT05678257","title":"A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":180,"lead_sponsor_name":"NuCana plc","has_results":true},{"nct_id":"NCT06271980","title":"Early-Onset Colorectal Cancer Recurrence","phase":"","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT06791512","title":"mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":166,"lead_sponsor_name":"Jun Huang","has_results":false},{"nct_id":"NCT07145255","title":"Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"MBrace Therapeutics","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}